Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 1, 2016
Perception of Fechner Illusory Colors in Alzheimer Disease PatientsGintaras Kaubrys, Vera Bukina, Ieva Bingelytė, et al.
Scientific Reports|April 13, 2023
Properties of odor identification testing in screening for early-stage Alzheimer's diseaseEgle Audronyte, Gyte Pakulaite-Kazliene, Vaiva Sutnikiene, et al.
Frontiers in Neurology|June 19, 2023
Olfactory memory in mild cognitive impairment and Alzheimer's diseaseEgle Audronyte, Vaiva Sutnikiene, Gyte Pakulaite-Kazliene, et al.
Frontiers in Neurology|June 11, 2025
Color memory as a diagnostic test for mild cognitive impairment and early stage of Alzheimer's diseaseVaiva Sutnikiene, Egle Audronyte, Gyte Pakulaite-Kazliene, et al.
Journal of Alzheimer'S Disease : JAD|June 25, 2023
Odor Discrimination as a Marker of Early Alzheimer's DiseaseEgle Audronyte, Gyte Pakulaite-Kazliene, Vaiva Sutnikiene, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 27, 2023
Brief Test of Olfactory Dysfunction Based on Diagnostic Features of Specific Odors in Early-Stage Alzheimer DiseaseEgle Audronyte, Vaiva Sutnikiene, Gyte Pakulaite-Kazliene, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 25, 2025
Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple SclerosisVera Taluntiene, Natasa Giedraitiene, Rasa Kizlaitiene, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 2, 2017
Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple SclerosisRasa Kizlaitienė, Gintaras Kaubrys, Nataša Giedraitienė, et al.
Multiple Sclerosis and Related Disorders|November 10, 2023
Autologous hematopoietic stem cell transplantation is superior to alemtuzumab in patients with highly active relapsing multiple sclerosis and severe disabilityMantas Vaisvilas, Gintaras Kaubrys, Rasa Kizlaitiene, et al.
European Neurology|January 11, 2007
Dementia and art: neuronal intermediate filament inclusion disease and dissolution of artistic creativityValmantas Budrys, Kari Skullerud, Donatas Petroska, et al.
Pageof 4